与衰老相关的大脑蛋白酶体动态的变化
Nodoka Nago1, Shigeo Murata2, Keiji Tanaka3
1Department of Clinical Nutrition, Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Japan.
Genes to cells : devoted to molecular & cellular mechanisms
|March 26, 2024
概括
蛋白质酶功能随着年龄的增长而下降,影响大脑健康. 这项研究揭示了与UMP1积累相关的蛋白质酶形成的减少,作为与年龄相关的认知衰退的关键因素.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 衰老研究研究 衰老研究
背景情况:
- 蛋白质体对于神经系统中的细胞平衡至关重要.
- 蛋白质体功能随着年龄的增长而下降,可能导致认知能力下降.
研究的目的:
- 调查导致大脑中与年龄相关的蛋白质酶功能下降的因素.
- 分析在衰老过程中蛋白酶体动态和形成的变化.
主要方法:
- 在不同年龄段对小鼠大脑组织的分析.
- 测量蛋白质酶酶活性. 测量蛋白质酶酶活性.
- 无处不在的蛋白质和蛋白酶子单元的量化.
- 对UMP1蛋白水平的评估.
主要成果:
- 蛋白质酶酶活性随着年龄的增长而降低.
- 随着年龄的增长,ubiquitinated蛋白和UMP1水平增加.
- 发现蛋白质酶的形成随着年龄的增长而减少.
结论:
- 与年龄相关的蛋白质酶体功能下降与蛋白质酶体形成的减少有关.
- 增加的UMP1积累是导致蛋白质酶形成受损的因素.
- 20S和26S蛋白质酶的功能随着年龄的增长而减弱,影响大脑健康.
相关概念视频
The Proteasome
832
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
832
Aging
49
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
49
The Proteasome Structure
749
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
749
Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
Mitochondria
12.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.4K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


